Inhibiting ferroptosis in type I hair cells of the utricle might be a promising strategy for treating cisplatin-induced vestibulotoxicity
Molecular Therapy · 2026
DOI: 10.1016/j.ymthe.2025.10.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Xiuli Bi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Institute of Brain Science and Brain-inspired Research, School of Cli…. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, Hair Cells, Vestibular, Saccule and Utricle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shandong Province, Natural Science Foundation of Henan Province, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Cisplatin-induced peripheral vestibular toxicity can significantly affect the quality of life of cancer patients undergoing treatment. In this study, we established a model of cisplatin-induced vestibulotoxicity that demonstrated significant vestibular dysfunction, closely mirroring the condition of cancer patients receiving cisplatin treatment. Following cisplatin administration, type I and type II vestibular hair cells (vHCs) exhibited progressive loss, with type I vHCs showing greater susceptibility to the drug. In vestibular tissues treated with cisplatin, evidence was found for the induction of ferroptosis, as indicated by alterations in several key ferroptosis regulator genes and the activation of ferroptosis biomarkers. Furthermore, these phenotypes were ameliorated by the administration of Fer-1. In Atoh1-Gpx4-/- mice vHCs, increases in reactive oxygen species and Fe2+, along with reductions in mitochondrial cristae, cell membrane rupture, and cytoplasmic vacuolation, suggest the activation of ferroptosis. Notably, the phenotypes observed in Atoh1-Gpx4-/- mice closely resembled those induced by cisplatin in the utricle. Our findings also demonstrated that the FDA-approved madecassic acid effectively mitigates vHC loss resulting from Gpx4 ablation and cisplatin administration through the modulation of Acsl3 and Gpx4. In summary, inhibiting ferroptosis may represent a potential strategy to protect against vestibular dysfunction caused by cisplatin-induced vestibulotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Institute of Brain Science and Brain-inspired Research, School of Clinical and Basic Medical Sciences, Shandong First Medical University &…
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Vertigo and Vestibular Medicine, Jinan, Shandong 25002…
- Shanxi Medical University, Taiyuan 030001, China.
- Department of Otology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
Förderung
- Natural Science Foundation of Shandong Province
- Natural Science Foundation of Henan Province
- Innovative Research Group Project of the National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
- China Postdoctoral Science Foundation
- Shandong First Medical University
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Bi, X., Zhou, J., Li, P., Song, Y., Liu, Z., Si, N., Shen, S., Li, W., Wu, Y., Zhao, X., Hong, G., Zhang, Y., Guo, S., Xiao, Y., Zhao, M., Yu, Y., Xia, M., Zhang, H., Zhang, D., & Fu, X. (2026). Inhibiting ferroptosis in type I hair cells of the utricle might be a promising strategy for treating cisplatin-induced vestibulotoxicity. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.10.032
Vancouver
Bi X, Zhou J, Li P, Song Y, Liu Z, Si N, et al. Inhibiting ferroptosis in type I hair cells of the utricle might be a promising strategy for treating cisplatin-induced vestibulotoxicity. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2025.10.032
BibTeX
@article{Bi2026,
author = {Bi, Xiuli and Zhou, Jing and Li, Peipei and Song, Yongdong and Liu, Ziyi and Si, Nannan and Shen, Shuyuan and Li, Wen and Wu, Yunhao and Zhao, Xiaoxu and Hong, Guodong and Zhang, Yuan and Guo, Siwei and Xiao, Yu and Zhao, Miaoqing and Yu, Yafeng and Xia, Ming and Zhang, Hanbing and Zhang, Daogong and Fu, Xiaolong},
title = {Inhibiting ferroptosis in type I hair cells of the utricle might be a promising strategy for treating cisplatin-induced vestibulotoxicity},
journal = {Molecular Therapy},
year = {2026},
doi = {10.1016/j.ymthe.2025.10.032}
}
EUVIMED